TickerFactsScreenerDevelopers

Niagen Bioscience, Inc. (NAGE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$7.86M2012: -$11.64M2013: -$4.39M2015: -$5.23M2016: -$2.91M2017: -$16.38M2018: -$33.17M2019: -$31.30M2020: -$19.85M2021: -$27.07M2022: -$18.63M2023: -$5.60M2024: $7.73M2025: $16.28M$16.28M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$16.28M+110.7%
2024$7.73M+238.0%
2023-$5.60M+69.9%
2022-$18.63M+31.2%
2021-$27.07M-36.4%
2020-$19.85M+36.6%
2019-$31.30M+5.6%
2018-$33.17M-102.6%
2017-$16.38M-463.7%
2016-$2.91M+44.5%
2015-$5.23M—
2013-$4.39M+62.3%
2012-$11.64M-48.0%
2011-$7.86M—